RBM3 and prostate cancer: Specifically, overexpression of RBM3 reduces the expression of CD44v8-v10 and promotes the splicing of CD44s, which is known to have an inhibitory effect on metastasis, thus reducing the stemness properties of prostate cancer cells (PC3 cells).